Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pulse Biosciences CS (PLSE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Pulse Biosciences, Inc.

Levi & Korsinsky announces it has commenced an investigation of Pulse Biosciences, Inc. ("Pulse" or the "Company") (NASDAQ:PLSE) concerning possible violations of federal securities laws....

PLSE : 15.02 (-7.63%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Pulse Biosciences, Inc. (PLSE)

NEW YORK , Sept. 11, 2017 /PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pulse Biosciences, Inc.  ("Pulse"...

PLSE : 15.02 (-7.63%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Pulse Biosciences, Inc. (PLSE)

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pulse Biosciences, Inc. ("Pulse" or the "Company") (Nasdaq: PLSE). Such investors...

PLSE : 15.02 (-7.63%)
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Pulse Biosciences, Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Pulse Biosciences, Inc. (NASDAQ: PLSE) resulting...

PLSE : 15.02 (-7.63%)
Pulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTx(TM) System

Pulse Biosciences, Inc. (Nasdaq:PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform, announced today...

PLSE : 15.02 (-7.63%)
The Big Deal About Stem Cell Therapies and Regenerative Medicine

LAS VEGAS, July 28, 2017 /PRNewswire/ --

CYTX : 0.39 (-4.88%)
PLSE : 15.02 (-7.63%)
ENDV : 0.0362 (+20.67%)
PSTI : 1.54 (-1.28%)
CAPR : 2.14 (+7.00%)
Pulse Biosciences Quarterly Investor and Analyst Conference Call

Pulse Biosciences, Inc. (Nasdaq: PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform today reports...

PLSE : 15.02 (-7.63%)
Investor Network: Pulse Biosciences, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / July 27, 2017 / Pulse Biosciences, Inc. (NASDAQ: PLSE) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, July 27, 2017 at 4:30 PM Eastern...

PLSE : 15.02 (-7.63%)
Congress Could Have Major Impact on Biotech Companies

LAS VEGAS, July 21, 2017 /PRNewswire/ --

OSUR : 21.74 (+0.60%)
FGEN : 51.35 (-2.93%)
ENDV : 0.0362 (+20.67%)
PLSE : 15.02 (-7.63%)
CAPR : 2.14 (+7.00%)
Congress Could Have Major Impact on Biotech Companies

LAS VEGAS, July 21, 2017 /PRNewswire/ --

OSUR : 21.74 (+0.60%)
FGEN : 51.35 (-2.93%)
PLSE : 15.02 (-7.63%)
ENDV : 0.0362 (+20.67%)
CAPR : 2.14 (+7.00%)
Pulse Biosciences to Host Quarterly Investor Conference Call on July 27, 2017

Pulse Biosciences, Inc., (Nasdaq: PLSE) a medical technology company developing a proprietary therapeutic tissue treatment platform based on Nano-Pulse Stimulation (NPS), will host its quarterly...

PLSE : 15.02 (-7.63%)
Pulse Biosciences Announces Treatment of First Patient in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation Technology for Seborrheic Keratosis Lesions

Pulse Biosciences, Inc. (Nasdaq:PLSE), a medical technology company developing a therapeutic tissue treatment platform based on its proprietary Nano-Pulse Stimulation (NPS) technology, today...

PLSE : 15.02 (-7.63%)
Kerrisdale Capital Issues Negative Report on Pulse Biosciences, Inc. and Announces Conference Call

Kerrisdale Capital, a private investment manager, has published a report explaining its short position in Pulse Biosciences, Inc. (NASDAQ:PLSE), a ~$400 million early-stage medical-device company developing...

PLSE : 15.02 (-7.63%)
Pulse Biosciences to Host Quarterly Investor Conference Call on May 4, 2017

Pulse Biosciences, Inc., (Nasdaq: PLSE) a medical technology company developing a proprietary therapeutic tissue treatment platform based on Nano-Pulse Stimulation (NPS), will host its quarterly...

PLSE : 15.02 (-7.63%)
Pulse Biosciences Update

On 3/28 in my Chart of the Day post I advised a short on Pulse Biosciences (PLSE) when it was trading at 32.20.  As I write this post it is trading at 19.07.  I don;t often...

PLSE : 15.02 (-7.63%)
Pulse Biosciences to Host Investor Conference Call on March 14, 2017

Pulse Biosciences, Inc., (Nasdaq: PLSE) a medical technology company developing a proprietary therapeutic tissue treatment platform based on Nano-Pulse Stimulation (NPS), will host its first...

PLSE : 15.02 (-7.63%)
Pulse Biosciences Announces Healthcare Executives and Entrepreneurs Robert Duggan and Dr. Maky Zanganeh Have Acquired a Combined Interest of 17.1% of the Company

Pulse Biosciences, Inc. (Nasdaq:PLSE), a medical technology company developing a proprietary therapeutic tissue treatment platform based on Nano-Pulse Stimulation (NPS), today announced that...

ABBV : 87.48 (+0.08%)
PLSE : 15.02 (-7.63%)

Van Meerten Stock Picks

5 Great Mid Caps
Today I wanted to find 5 Mid Cap stocks that had a high gain over the last year and continue to have current momentum.
DAN +0.41 , IPGP +4.16 , TEX -0.46 , NVR +29.06 , TTWO +1.12
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Dec E-mini S&Ps ( ESZ17 -0.14% ) this morning are down -0.09% on heightened North Korean tensions after North Korean President Kim Jong Un promised the "highest level of hardline" countermeasures against the U.S.... Read More

Chart of the Day

Chart of the Day

Fiat Chrysler Automobiles (FCAU) is the Barchart Chart of the Day.  The international auto producer has a Trend Spotter buy signal, a Weighted Alpha of 190.70+ and gained 174.92% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures settled Friday with 2 to 3 1/2 cent gains, as Dec was 1 1/4 cent lower on the week. Rains over the next week could slow corn harvest in most of the WCB. Next Friday at 11:00 a.m. will be the release of the Sept 1 Grain Stocks report. The...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.